tiprankstipranks
Climb Bio (CLYM)
NASDAQ:CLYM
US Market
CLYM
Climb Bio
RESEARCH TOOLSreports
Want to see CLYM full AI Analyst Report?

Climb Bio (CLYM) Income Statement

697 Followers

Climb Bio Income Statement

Last quarter (Q4 2025), Climb Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Climb Bio's net income was $-17.52M. See Climb Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -97.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 67.79M$ 82.02M$ 40.27M$ 45.13M$ 35.67M
Depreciation and Amortization
$ 97.00K$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -67.79M$ -30.36M$ -40.27M$ -45.13M$ -35.67M
Operating Income
$ -67.88M$ -82.02M$ -40.27M$ -45.13M$ -35.67M
Other Income/Expenses
$ 8.03M$ 8.12M$ 5.16M$ -109.00K$ -11.81M
Pretax Income
$ -59.85M$ -73.90M$ -35.12M$ -45.24M$ -47.48M
Net Income
$ -59.85M$ -73.90M$ -35.12M$ -45.24M$ -47.48M
Per Share Metrics
Basic EPS
$ -0.88$ -1.14$ -1.30$ -1.72$ -4.24
Diluted EPS
$ -0.88$ -1.14$ -1.30$ -1.72$ -4.24
Weighted Average Shares Outstanding
 67.81M 48.16M 26.99M 26.31M 12.26M
Weighted Average Shares Outstanding (Diluted)
 67.81M 48.16M 26.99M 26.31M 12.26M
Currency in USD

Climb Bio Earnings and Revenue History